Argentinian Provincial Ministry of Health just published the results of a retrospective study of a trial of over 21,000 participants. The results were unmistakable among those participants above age 40, all non-vaccinated. Overall, when adjusting for confounding factors like less healthy people joining the ivermectin group, those in the ivermectin group had a 66% lower ICU admission rate and a 55% lower mortality rate than those in the control group. Anyone in the ivermectin group was treated with a dose of 0.6mg per kg of weight one time a day for five days.